A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)

Clinical trial NCT06756126 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06756126
Sponsor: Akeso
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2024-12-30
Primary completion: 2025-06-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.